HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroyuki Ishiura Selected Research

Leukoencephalopathies

3/2018A Homozygous LAMA2 Mutation of c.818G>A Caused Partial Merosin Deficiency in a Japanese Patient.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroyuki Ishiura Research Topics

Disease

7Dementia (Dementias)
01/2023 - 04/2015
5Parkinsonian Disorders (Parkinsonism)
01/2023 - 02/2016
5Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
07/2022 - 01/2012
4Alzheimer Disease (Alzheimer's Disease)
01/2024 - 04/2016
4Multiple System Atrophy
05/2023 - 01/2016
4Parkinson Disease (Parkinson's Disease)
01/2022 - 07/2010
3Epilepsy (Aura)
04/2024 - 01/2018
3Inflammation (Inflammations)
04/2024 - 07/2022
3Muscular Diseases (Myopathy)
10/2023 - 01/2022
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2022 - 01/2018
3Hereditary Spastic Paraplegia
07/2022 - 02/2012
2Cognitive Dysfunction
01/2024 - 10/2018
2Mitochondrial Diseases (Mitochondrial Disease)
12/2023 - 07/2022
2Myoclonic Epilepsies (Myoclonic Encephalopathy)
09/2023 - 06/2023
2Gaucher Disease (Gaucher's Disease)
08/2023 - 04/2015
2Demyelinating Diseases (Demyelinating Disease)
01/2023 - 01/2020
2Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked)
01/2023 - 01/2020
2Frontotemporal Dementia (Semantic Dementia)
01/2023 - 11/2022
2Paraplegia (Spastic Paraplegia)
07/2022 - 02/2012
2Amyloidosis
07/2022 - 06/2022
2Inborn Genetic Diseases (Disease, Hereditary)
01/2022 - 03/2014
2Spinocerebellar Ataxias (Spinocerebellar Ataxia)
10/2019 - 01/2018
2Intellectual Disability (Idiocy)
01/2018 - 04/2014
1Status Epilepticus (Complex Partial Status Epilepticus)
04/2024
1Gliosis
01/2024
1Vascular Remodeling
01/2024
1Reperfusion Injury
01/2024
1Ischemic Stroke
01/2024
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2024
1Stroke (Strokes)
01/2024
1Cerebral Infarction
01/2024
1Brain Ischemia (Cerebral Ischemia)
01/2024
1Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
11/2023
1Myofibrillar Myopathy
10/2023
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
10/2023
1Woodhouse Sakati syndrome
09/2023
1Dystonia (Limb Dystonia)
09/2023
1X-Linked Torsion Dystonia 3
09/2023
1Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy)
09/2023
1Familial paroxysmal dystonia
09/2023
1Neurologic Manifestations (Neurological Manifestations)
08/2023
1Globoid Cell Leukodystrophy (Krabbe Disease)
08/2023
1Type 1 Benign Adult Familial Myoclonic Epilepsy
06/2023
1Ataxia (Dyssynergia)
05/2023
1Pancreatitis
05/2023
1Diarrhea
04/2023
1Hepatolenticular Degeneration (Wilson's Disease)
04/2023
1Deglutition Disorders (Dysphagia)
04/2023
1Type 2F Charcot-Marie-Tooth disease
01/2023
1Tomaculous neuropathy
01/2023
1Neuronal intranuclear inclusion disease
01/2023
1Neurocognitive Disorders (Clerambault Syndrome)
01/2023
1Atrophy
01/2023
1Atrial Fibrillation
01/2023
1Corticobasal Degeneration
01/2023

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2012
4RNA (Ribonucleic Acid)IBA
12/2023 - 01/2018
4DNA (Deoxyribonucleic Acid)IBA
07/2022 - 03/2014
3EnzymesIBA
11/2023 - 08/2020
3coenzyme Q10 (CoQ10)IBA
05/2023 - 01/2016
3Biomarkers (Surrogate Marker)IBA
01/2023 - 10/2018
3Glucosylceramidase (Glucocerebrosidase)IBA
01/2019 - 07/2010
2NucleotidesIBA
01/2024 - 01/2018
2ubiquinolIBA
05/2023 - 01/2017
2Myelin P0 Protein (Myelin Protein Zero)IBA
01/2021 - 01/2012
2Nonsense Codon (Nonsense Mutation)IBA
08/2013 - 12/2012
1Hypnotics and Sedatives (Sedatives)IBA
04/2024
1tocilizumab (atlizumab)FDA Link
04/2024
1PlasmalogensIBA
01/2024
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2024
1Receptor for Advanced Glycation End ProductsIBA
01/2024
1Leucine-Rich Repeat ProteinsIBA
01/2024
1InflammasomesIBA
01/2024
1Neuroprotective AgentsIBA
01/2024
1FlavonoidsIBA
01/2024
1Sirtuin 1IBA
01/2024
1sudachitinIBA
01/2024
1Tripeptidyl-Peptidase 1IBA
11/2023
1cerliponase alfaIBA
11/2023
1DesminIBA
10/2023
1Endopeptidase K (Proteinase K)IBA
10/2023
1Calmodulin (Calcium-Dependent Activator Protein)IBA
09/2023
1GalactosylceramidaseIBA
08/2023
1Dietary Fats (Dietary Fat)IBA
05/2023
1CopperIBA
04/2023
1ZincIBA
04/2023
1Amyloid beta-PeptidesIBA
01/2023
1Fibrinogen (Factor I)FDA Link
01/2023
1Small Heat-Shock ProteinsIBA
01/2023
1Therapeutic UsesIBA
01/2023
1Homovanillic AcidIBA
01/2023
1Acetic Acid (Vinegar)FDA LinkGeneric
01/2023
1Levodopa (L Dopa)FDA LinkGeneric
01/2023
1AnticoagulantsIBA
01/2023
1Myelin ProteinsIBA
01/2023
1RivaroxabanIBA
01/2023
15-hydroxyindoleIBA
01/2023

Therapy/Procedure

1Long-Term Care
08/2023
1Enzyme Replacement Therapy
08/2023
1Hematopoietic Stem Cell Transplantation
08/2023